Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
60,079.18 -2,634.64 (-4.20%) CMC Crypto 200
1,277.98 -61.09 (-4.56%)
Blueprint Medicines Corporation (BPMC)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:34PM EDT. Market open.
| Previous close | 93.10 |
| Open | 91.45 |
| Bid | 91.59 x 100 |
| Ask | 91.92 x 100 |
| Day's range | 90.75 - 93.00 |
| 52-week range | 43.89 - 101.00 |
| Volume | |
| Avg. volume | 805,985 |
| Market cap | 5.771B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -8.37 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 98.00 |
ZacksWill Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
Apellis Pharmaceuticals (APLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksBlueprint Medicines (BPMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Blueprint Medicines (BPMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PR NewswireBlueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024, to report its first quarter 2024 financial results and provide a corporate update.
© 2024 Yahoo. All rights reserved.